Peterson, S., Nunes, E. V., Lofwall, M. R., Walsh, S. L., & Tiberg, F. (2024). Exploring Opioid Use Disorder Outcomes by Quantitative Urinalysis: Post Hoc Analysis of a Phase 3 Randomized Clinical Trial. Journal of Addiction Medicine. https://doi.org/10.1097/adm.0000000000001405

Elkington, K. S., Ryan, M. E., Basaraba, C., Dambreville, R., Alschuler, D., Wall, M. M., Garcia, A., Christofferson, M., Andrews, H. F., & Nunes, E. V. (2024). Examining the Impact of the Innovative Opioid Court Model on Treatment Access and Court Outcomes for Court Participants. Journal of Addiction Medicine, 18(6), 635–642. https://doi.org/10.1097/adm.0000000000001330

Sung, M. L., Black, A. C., Blevins, D., Henry, B. F., Cates-Wessel, K., Dawes, M. A., Hagle, H., Joudrey, P. J., Molfenter, T., Levin, F. R., Fiellin, D. A., & Edelman, E. J. (2024). Clinician and Practice Characteristics Associated With Support of Office-Based Methadone: Findings From a National Survey. Journal of Addiction Medicine. https://doi.org/10.1097/adm.0000000000001388

Nunes, E. V., & McLellan, A. T. (2024). The Concept of Treatment-Refractory Addiction: Implications for Addiction Treatment Systems and Research. Journal of Addiction Medicine, 18(5), 477–479. https://doi.org/10.1097/adm.0000000000001350

Lim, T. Y., Keyes, K. M., Caulkins, J. P., Stringfellow, E. J., Cerdá, M., & Jalali, M. S. (2024). Improving Estimates of the Prevalence of Opioid Use Disorder in the United States: Revising Keyes et al. Journal of Addiction Medicine, 18(6), 705–710. https://doi.org/10.1097/adm.0000000000001375

Tardelli, V. S., Fidalgo, T. M., & Martins, S. S. (2024). Z-Drug Use and Benzodiazepine Use and Misuse Among LGB Populations: The Role of Psychological Distress. Journal of Addiction Medicine. https://doi.org/10.1097/adm.0000000000001309

Perez, H. R., Deng, Y., Zhang, C., Groeger, J. L., Glenn, M., Richard, E., Pazmino, A., De La Cruz, A. A., Prinz, M., & Starrels, J. L. (2024). Trajectories of Opioid Misuse and Opioid Use Disorder Among Adults With Chronic Pain and HIV: An Observational Study. Journal of Addiction Medicine, 18(2), 174–179. https://doi.org/10.1097/adm.0000000000001268

Castillo, F., Harris, H. M., Lerman, D., Bisaga, A., Nunes, E. V., Zhang, Z., Wall, M., & Comer, S. D. (2023). Clinical Implications of the Relationship Between Naltrexone Plasma Levels and the Subjective Effects of Heroin in Humans. Journal of Addiction Medicine, 18(2), 110–114. https://doi.org/10.1097/adm.0000000000001247

Fink, D. S., Malte, C., Cerdá, M., Mannes, Z. L., Livne, O., Martins, S. S., Keyhani, S., Olfson, M., McDowell, Y., Gradus, J. L., Wall, M. M., Sherman, S., Maynard, C. C., Saxon, A. J., & Hasin, D. S. (2023). Trends in Cannabis-positive Urine Toxicology Test Results: US Veterans Health Administration Emergency Department Patients, 2008 to 2019. Journal of Addiction Medicine, 17(6), 646–653. https://doi.org/10.1097/adm.0000000000001197

Shulman, M., Choo, T.-H., Scodes, J., Pavlicova, M., Novo, P., Campbell, A. N. C., Greiner, M., Lee, J. D., Rotrosen, J., & Nunes, E. V. (2023). Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use Disorder. Journal of Addiction Medicine, 17(5), 618–620. https://doi.org/10.1097/adm.0000000000001173

Justen, M., Scodes, J., Pavlicova, M., Choo, T.-H., Gopaldas, M., Haeny, A., Opara, O., Rhee, T. G., Rotrosen, J., Nunes, E. V., Hawk, K., & Edelman, E. J. (2023). Homelessness and Treatment Outcomes Among Black Adults With Opioid Use Disorder: A Secondary Analysis of X:BOT. Journal of Addiction Medicine, 17(4), 463–467. https://doi.org/10.1097/adm.0000000000001125

Seval, N., Nunez, J., Roth, P., Schade, M., Strong, M., Frank, C. A., Litwin, A. H., Levin, F. R., Brady, K. T., Nunes, E. V., & Springer, S. A. (2023). Inpatient Low-dose Transitions From Full Agonist Opioids Including Methadone Onto Long-acting Depot Buprenorphine: Case Series From a Multicenter Clinical Trial. Journal of Addiction Medicine, 17(4), e232–e239. https://doi.org/10.1097/adm.0000000000001136

Tofighi, B., Badiei, B., Badolato, R., Lewis, C. F., Nunes, E., Thomas, A., & Lee, J. D. (2023). Integrating Text Messaging in a Low Threshold Telebuprenorphine Program for New York City Residents with Opioid Use Disorder during COVID-19: A Pilot Randomized Controlled Trial. Journal of Addiction Medicine, 17(5), e281–e286. https://doi.org/10.1097/adm.0000000000001161

Sung, M. L., Black, A. C., Blevins, D., Henry, B. F., Cates-Wessel, K., Dawes, M. A., Drexler, K., Hagle, H., Molfenter, T., Levin, F. R., Becker, W. C., & Edelman, E. J. (2022). Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of Prescribers. Journal of Addiction Medicine, 16(5), 505–513. https://doi.org/10.1097/adm.0000000000000948

Shulman, M., Hu, M. C., Nunes, E. V., & Bisaga, A. (2022). Initiating Long-acting Injectable Naltrexone: Procedure for a Second Attempt After a First Attempt Fails. Journal of Addiction Medicine, 16(5), 588–591. https://doi.org/10.1097/adm.0000000000000974

Lee, J. D., Nunes, E. V., Novo, P., May, J., Matthews, A., Van Veldhuisen, P., Lindblad, R., Liu, D., & Rotrosen, J. (2022). Commentary on Ajazi et al (2021) Re-analysis of the X:BOT Trial. Journal of Addiction Medicine, 16(4), 382–385. https://doi.org/10.1097/adm.0000000000000930

Aldridge, A. P., Zarkin, G. A., Dowd, W. N., Witkiewitz, K., Hasin, D. S., O’Malley, S. S., Isenberg, K., & Anton, R. F. (2021). The Relationship Between Reductions in WHO Risk Drinking Levels During Treatment and Subsequent Healthcare Costs for the ACTIVE Workgroup. Journal of Addiction Medicine, 16(4), 425–432. https://doi.org/10.1097/adm.0000000000000925